Faculty Collaboration Database

1. Findling JW, Pohlmann GP, and Rose HD: Fulminant gram negative bacillemia (DF 2) following a dog bite in an asplenic woman. Am J Med 68:154 156, 1980.

2. Findling JW, Beckstrom D, Rawsthorne L, Kozin F, and Itskovitz H: Indomethacin induced hyperkalemia in three patients with gouty arthritis. JAMA 244:1127 1128, 1980.

3. Aron DC, Tyrrell JB, Fitzgerald PA, Findling JW, and Forsham PH: Cushing's syndrome: problems in diagnosis. Medicine 60:25 35, 1981.

4. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, and Forsham PH: Silent pituitary apoplexy: subclinical infarction of an ACTH producing pituitary adenoma. J Clin Endocrinol Metab 52:95 97, 1981.

5. Findling JW and Rose HD: Thrombotic thrombocytopenic purpura after a dog bite (Letter to the Editor). South Med J 74:89, 1981.

6. Findling JW, Aron DC, Tyrrell JB, Shinsako JH, Fitzgerald PA, Norman D, Wilson CB, and Forsham PH: Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing's disease and the ectopic ACTH syndrome. Ann Intern Med 94:647 652, 1981.

7. Aron DC, Findling JW, Tyrrell JB, Fitzgerald PA, Brooks RM, Fisher FE, and Forsham PH: Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature. Am J Med 71:302 306, 1981.

8. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Young CW, and Sohnle PE: Superficial fungal infections in Cushing's syndrome (Letter to the Editor). Ann Intern Med 95:392, 1981.

9. Fitzgerald PA, Aron DC, Findling JW, Brooks RM, Wilson CB, Forsham PH, and Tyrrell JB: Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas: evidence for a pituitary origin. J Clin Endocrinol Metab 54:413 422, 1982.

10. Aron DC, Findling JW, Fitzgerald PA, Forsham PH, Wilson CB, and Tyrrell JB: Cushing's syndrome: problems in management. Endocrin Rev 3:229, 1982.

11. Findling JW, Adams ND, Lemann J Jr, Gray RW, Thomas CJ and Tyrrell JB: Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab 54:1039 1044, 1982.

12. Findling JW, Dallman MF, Wilson CB, and Tyrrell JB: Defect in ACTH control after hypophysectomy in Cushing's disease. N Engl J Med 306:680, 1982 .

13. Gogel EL, Salber PR, Tyrrell JB, Rosenblum ML, and Findling JW: Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor: spontaneous development and remission. Arch Intern Med 143:1040 1042, 1983.

14. Cusick JF, Hagen TC, Findling JW: Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med 311:36 38, 1984.

15. Findling JW, Tyrrell JB: Occult ectopic secretion of corticotropin. Arch Intern Med 146:929 933, 1986.

16. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH: An overnight high dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 104:180 186, 1986.

17. Findling JW, Buggy BP, Segerson TP, Raff H: Pneumocystis carinii pneumonia complicating intermittent Cushing's syndrome. Wisc Med J 85:23 25, 1986.

18. Findling JW, Korducki JM, Lahiri PK, Miller DD, Raff H: Bilateral adrenal hemorrhage associated with heparin induced thrombocytopenia. Wis Med J 86:27 29, 1987.

19. Findling JW, Waters VO, Raff H: The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 64:592 595, 1987.

20. Raff H, Norton AJ, Flemma RJ, Findling JW: Inhibition of the ACTH response to surgery in humans: interaction between dexamethasone and fentanyl. J Clin Endocrinol Metab 65:295 298, 1987.

21. Findling JW, Adams AH, Raff H: Selective hypoaldosteronism due to an endogenous impairment in angiotensin II production. N Engl J Med 316:1632 1635, 1987.

22. Pachucki L, Gotch P, Shaker J, Findling J: Flocculation of human insulin preparations. Ann Intern Med 107:781, 1987.

23. Raff H, Flemma RJ, Findling JW: Fast cortisol induced inhibition of the adrenocorticotropin response to surgery in humans. J Clin Endocrinol Metab 67:1146 1148, 1988.

24. Raff H, Findling JW: A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 35:596 600, 1989.

25. Lewin RF, Raff H, Findling JW, Skelton MM, Cowley AW, King JF, Dorros G: Stimulation of atrial natriuretic peptide and vasopressin during percutaneous transluminal aortic valvulo plasty. Amer Heart J 118: 292 298, 1989.

26. Raff H, Findling JW, Wong J: Short loop adrenocorticotropin feedback after ACTH (1 24) injection in man is an artifact of the immunoradiometric assay. J Clin Endocrinol Metab 69:678 680, 1989.

27. Findling JW, Shaker JL, Larson P: Thyroid needle aspiration in a community hospital. Wis Med J 88:19 22, 1989.

28. Findling JW: The Cushing syndromes: an enlarging clinical spectrum. (Editorial) N Engl J Med 321:1677 78,1989.

29. Findling JW, Buggy BP: Thyroid hormones and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111:951,1989.

30. Rich LM, Caine MR, Findling JW, Shaker JL: Hypoglycemic coma in anorexia nervosa: case report and review of the literature. Arch Intern Med 150:894 895, 1990.

31. Raff H, Findling JW: Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med 18:915 920, 1990.

32. Findling JW, Engeland WC, Raff H: The use of immunoradiometric assay for the measurement of ACTH in human plasma. Trends Endo Metab 1:283 287, 1990.

33. Lewin RF, Raff H, Findling JW, Skelton MM, Cowley AW, Dorros G: Stimulation of atrial natriuretic peptide and vasopressin during retrograde mitral valvuloplasty. Am Heart J 120:1305 1310, 1990.

34. Shaker JL, Krawczyk KW, Findling JW: Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25 dihydroxyvitamin D. J Clin Endocrinol Metab 71:1305 1309, 1990.

35. Findling JW: Eutopic or ectopic adrenocorticotropic hormone dependent Cushing's Syndrome? A diagnostic dilemma. (Editorial) Mayo Clinic Proceed 65:1377 1380, 1990.

36. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, Ling A, Travis WD, Cutler GB, Chrousos GP, Loriaux DL: The detection of ACTH producing bronchial carcinoid tumors: comparison of MR imaging with CT. Am J Roentgen 156:39 43, 1991.

37. Findling JW, Kehoe ME, Shaker JL, Raff H: Routine inferior petrosal sinus sampling in the differential diagnosis of ACTH dependent Cushing's syndrome: Early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab 73:408 413, 1991.

38. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling, JW: Secondary hyperparathyroidism and osteopenia following gastric exclusion surgery for obesity. Osteoporosis International 1:177 181, 1991.

39. Dankle SK, Kidder TM, Findling JW: Tracheoesophageal complications of thyroid disease. Laryngoscope 102:739 746,1992.

40. Findling JW: Clinical application of a new immunoradiometric assay for ACTH. The Endocrinologist. 2:360 365,1992.

41. Findling JW: Cushing syndrome an etiologic work up. Hospital Practice 27:107 122,1992.

42. Shaker JL, Auger GE, Wendt PP, Findling JW: Hypercalcemia associated with dysregulation of 1,25 dihydroxyvitamin D in arthritis. J Endocrinol Invest 15:771 775,1992.

43. Slyper AH, Findling JW: Use of a two site immunoradiometric assay to resolve factitious elevation of ACTH in primary pigmented nodular adrenocortical disease. J Ped Endocrinol 7:61 63,1994.

44. Shaker JL, Redlin KC, Warren GV, Findling JW: Hypercalcemia with inappropriate 1,25 dihydroxyvitamin D in Wegener's granulomatosis. Am J Med Sci 308:115 118,1994..

45. Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein BM, Raff H: Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab 79:1091 1096,1994..

46. Raff H, Shaker JL, Nelson DK, Findling JW: Rapid measurement of corticotropin (ACTH) using a modified immunochemiluminescent assay. Clin Chem 40:1344,1994.

47. Shimkets RA, Warnock DG, Bositis CM, Nelson Williams C, Hansson JH, Schambelan M, Gill JR, Vlick S, Milora RV, Findling JW, Canessa CNM, Rossier BC, Lifton RP: Liddle's syndrome: heritable human hypertension caused by mutation in the b subunit of the epithelial sodium channel. Cell 79:4070414,1994.

48. Kay J, Findling JW, Raff H: Epidural triamcinolone suppresses the pituitary adrenal axis in human subjects. Anesthesia and Analgesia 79:501 505,1994.

49. Wahle JS, Hanson JP, Shaker JL, Findling JW: Primary adrenal insufficiency after treatment with interleukin 2 and tumor infiltrating lymphocytes. Endo Prac 1: 45 48, 1995.

50. Raff H, Shaker JL, Seifert PE, Werner PH, Hazelrigg SR, Findling JW: Intraoperative measurement of adrenocorticotropin (ACTH) during removal of ACTH secreting bronchial carcinoid tumors. J Clin Endocrinol Metab 80:1036 1039,1995.

51. Shaker JL, Brickner RC, Divgi AB, Raff H, Findling JW: Renal phosphate wasting, syndrome of inappropriate antidiuretic hormone, and ectopic corticotropin production in small cell carcinoma. Am J Med Sci 310: 38 41, 1995.

52. O'Shaughnessy IM, Raff H, Findling JW: Factitious Cushing's syndrome: discovery with the use of a sensitive immunoradiometric assay for ACTH. Endo Prac 1: 327 329, 1995.

53. Findling JW, Cerletty JM, Rapp RJ, McGreevy RB: Results of a community thyroid screening program: Who will benefit? Endo Prac 4: 237 242, 1996.

54. Findling JW, Shaker JL, Brickner RC, Riordan P, Aron DC: Curbside consultation in endocrinology: a prospective observational study. The Endocrinologist 6: 328 331, 1996.

55. Repaske DR, Medlej R, Gultekin EK, Krishnamani MRS, Halaby G, Findling JW, Phillips JA: Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus causes by a mutation encoding A1a-1 - Val in the signal peptide of the arginine vasopression/neurophysin II/Copeptin Precursor. J Clin Endocrinol Metab 82:51-56, 1997.

56. Shaker JL, Brickner RC, Findling JW, Kelly TM, Rap R, Rizk G, Haddad JG, Schalch DS, Shenker Y: Hypocalcemia and/or skeletal disease as presenting features of gluten-sensitive enteropathy. Arch Intern Med 157:1013-1016, 1997.

57. Findling JW, Raff H, Hansson JH, Lifton RP: Liddle's syndrome: Prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 82:1071-1074, 1997.

58. Findling JW: Differential diagnosis of Cushing's syndrome. The Endocrinologist 7:17S-23S, 1997

59. Aron DC, Raff H, Findling JW: Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab, 82: 1780-1785, 1997.

60. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC: Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. The Endocrinologist 8:51-54, 1998.

61. Raff H, Raff J, Findling JW: Late-night salivary cortisol as a screening test for Cushing's Syndrome. J Clin Endocrinol Metab, 83: 2681-2686, 1998.

62. Findling JW: Inferior petrosal sinus sampling: peril, pitfalls and progress (Editorial). Endo Prac 4: 426 486, 1998.

63. Lalande BM and Findling JW: Amelioration of licorice-induced hypokalemic rhabdomyolysis with dexamethasone: a case report and review of the literature. The Endocrinologist 8:359-363, 1998

64. Findling JW: Inferior petrosal sinus sampling: pros and cons; when and where. J Endocrinol Invest 23:193 195, 2000.

65. Whitcomb JE, Findling JW, Raff H, Harnsher K: Randomized trial of oral hydrocortisone and its effect on emergency physicians during night duty. Wisconsin Med J, 99: 37-41, 2000.

66. Semple Pl, Vance ML, Findling JW, Laws Jr. ER: Transsphenoidal surgery for Cushing Disease: Outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery, 46:553-559, 2000

67. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Findling JW: Comparison of adrenal vein sampling and computed tomogrophy in the differentiation of primary aldosteronism. J Clin Endocrinol Metab, 86:1066-1071, 2001.

68. Raff H, Shaker JL, Magill SB, Kehoe ME, Findling JW: PTHrp during petrosal sinus sampling. Clinical Endocrinology 56:417-420,2002.

69. Shaker JL, Magill SB, Lalande BM, Brickner RC, Findling JW: Endocrine manifestations of celiac disease. The Endocrinologist 12:110-116;2002.

70. Raff H, Findling JW: A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980-991, 2003.

71. Meikle AW, Findling J, Kushnier MM, Rockwood AL, Nelson GJ, Terry AH: Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance chromatography. J Clin Endocrinol Metab 88:3521-3524, 2003.

72. Arnaldi G, Angel A, Atkinson AB, Bertogna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M: Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602,2003.

73. Findling JW, Raff H, Aron DC: The low-dose dexamethasone suppression test: a re-evaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 89:1222-1226, 2004.

74. Findling JW, Kehoe, ME, Raff H: Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin (ACTH) gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent. J Clin Endocrinol Metab 89:6005-6009, 2004.

75. Findling JW, Raff H: Cushing's syndrome: important issues in diagnosis and treatment. J Clin Endocriol Metab 91:3746-3753, 2006.

76. Kidambi S, Raff H, Findling JW: Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. European J Endocrinol 157: 725-731, 2007.

77. Carroll T, Raff H, Findling JW: Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome. Nature Clinical Practice Endocrinology & Metabolism 6:344-350, 2008.

78. Nieman LK, Biller BMK, Findling JW, Newell-price J, Savage MO, Stewart PM, Monton VM. The diagnosis of Cushing's syndrome: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:1526-1540, 2008.

79. Raff H, Brock S, Findling JW: Cosyntropin-stimulated salivary cortisol in hospitalized patients with hypoproteinemia. Endocrine 34(1-3):68-74, 2008.

80. Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BMK, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, and Bertherat J: Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase III trial. J Clin Endocrinol Metab 94: 115-122, 2009.

81. Mepani J, Findling JW: Reversible bone marrow edema of the hip due to severe hypothyroidism. J Clin Endocrinol Metab 94:1068, 2009.

82. Carroll T, Raff H, Findling JW: Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocrine Practice 15(4):335-42, 2009.

83. Carroll T, Findling JW: Cushing's syndrome of non-pituitary causes. Current Opinion in Endocrinology, Diabetes, and Obesity 16:308-315, 2009.

84. Carroll TB, Findling JW: The diagnosis of Cushing's syndrome. Reviews in Endocrine Metab Disorders 11(2):147-153, 2010.

85. Raff H, Findling JW: Salivary cortisol or cortisone? Nature Reviews (Endocrinology) 6:658-660,2010.

86. Findling JW, Pohlmann GP, Rose HD. Fulminant gram-negative bacillemia (DF-2) following a dog bite in an asplenic woman. Am J Med. 1980 Jan;68(1):154-6.

87. Findling JW, Beckstrom D, Rawsthorne L, Kozin F, Itskovitz H. Indomethacin-induced hyperkalemia in three patients with gouty arthritis. JAMA. 1980 Sep 05;244(10):1127-8.

88. Findling JW, Rose HD. Purpura after dogbite. South Med J. 1981 Jan;74(1):89.

89. Aron DC, Tyrrell JB, Fitzgerald PA, Findling JW, Forsham PH. Cushing's syndrome: problems in diagnosis. Medicine (Baltimore). 1981 Jan;60(1):25-35.

90. . Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature American Journal of Medicine. 1981;71(2):302-306.

91. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH. Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab. 1981 Jan;52(1):95-7.

92. Findling JW, Aron DC, Tyrrell JB, Shinsako JH, Fitzgerald PA, Norman D, Wilson CB, Forsham PH. Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome. Ann Intern Med. 1981 May;94(5):647-52.

93. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Young CW, Sohnle PG. Fungal infections in Cushing's syndrome. Ann Intern Med. 1981 Sep;95(3):392.

94. Aron DC, Findling JW, Fitzgerald PA, Forsham PH, Wilson CB, Tyrrell JB. Cushing's syndrome: problems in management. Endocr Rev. 1982;3(3):229-44.

95. Aron DC, Findling JW, Fitzgerald PA, Brooks RM, Fisher FE, Forsham PH, Tyrrell JB. Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature. Am J Med. 1981 Aug;71(2):302-6.

96. Fitzgerald PA, Aron DC, Findling JW, Brooks RM, Wilson CB, Forsham PH, Tyrrell JB. Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab. 1982 Feb;54(2):413-22.

97. . Defect in ACTH control after hypophysectomy in Cushing's disease. N Engl J Med. 1982 Mar 18;306(11):679-80.

98. Findling JW, Adams ND, Lemann J Jr, Gray RW, Thomas CJ, Tyrrell JB. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 1982 May;54(5):1039-44.

99. Gogel EL, Salber PR, Tyrrell JB, Rosenblum ML, Findling JW. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission. Arch Intern Med. 1983 May;143(5):1040-2.

100. Cusick JF, Hagen TC, Findling JW. Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med. 1984 Jul 05;311(1):36-8.

101. Findling JW, Tyrrell JB. Occult ectopic secretion of corticotropin. Arch Intern Med. 1986 May;146(5):929-33.

102. Findling JW, Buggy BP, Segerson TP, Raff H. Pneumocystis carinii pneumonia complicating intermittent Cushing's syndrome. Wis Med J. 1986 Sep;85(9):23-5.

103. Findling JW, Korducki JM, Lahiri PK, Miller DD, Raff H. Bilateral adrenal hemorrhage associated with heparin-induced thrombocytopenia. Wis Med J. 1987 Mar;86(3):27-9.

104. Findling JW, Waters VO, Raff H. The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab. 1987 Mar;64(3):592-5.

105. Findling JW, Adams AH, Raff H. Selective hypoaldosteronism due to an endogenous impairment in angiotensin II production. N Engl J Med. 1987 Jun 25;316(26):1632-5.

106. Raff H, Norton AJ, Flemma RJ, Findling JW. Inhibition of the adrenocorticotropin response to surgery in humans: interaction between dexamethasone and fentanyl. J Clin Endocrinol Metab. 1987 Aug;65(2):295-8.

107. Aron DC, Findling JW, Tyrrell JB. Cushing's disease. Endocrinol Metab Clin North Am. 1987 Sep;16(3):705-30.

108. Pachucki L, Gotch P, Shaker J, Findling J. Flocculation of insulin preparations. Ann Intern Med. 1987 Nov;107(5):781.

109. Singer F, Kalin MF. Selective hypoaldosteronism and impairment of angiotensin II production. N Engl J Med. 1987 Dec 31;317(27):1739-40.

110. Raff H, Flemma RJ, Findling JW. Fast cortisol-induced inhibition of the adrenocorticotropin response to surgery in humans. J Clin Endocrinol Metab. 1988 Dec;67(6):1146-8.

111. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem. 1989 Apr;35(4):596-600.

112. Lewin RF, Raff H, Findling JW, Skelton MM, Cowley AW Jr, King JF, Dorros G. Stimulation of atrial natriuretic peptide and vasopressin during percutaneous transluminal aortic valvuloplasty. Am Heart J. 1989 Aug;118(2):292-8.

113. Raff H, Findling JW, Wong J. Short loop adrenocorticotropin (ACTH) feedback after ACTH-(1-24) injection in man is an artifact of the immunoradiometric assay. J Clin Endocrinol Metab. 1989 Sep;69(3):678-80.

114. Findling JW, Shaker JL, Larson PR. Thyroid needle aspiration in a community hospital. Wis Med J. 1989 Oct;88(10):19-22.

115. Findling JW, Buggy BP. Thyroid hormones and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Dec 01;111(11):951.

116. Findling JW. The Cushing syndromes: an enlarging clinical spectrum. N Engl J Med. 1989 Dec 14;321(24):1677-8.

117. Findling JW, Engeland WC, Raff H. The use of immunoradiometric assay for the measurement of ACTH in human plasma Trends in Endocrinology and Metabolism. July 1990/August 1990;1(6):283-287.

118. Rich LM, Caine MR, Findling JW, Shaker JL. Hypoglycemic coma in anorexia nervosa. Case report and review of the literature. Arch Intern Med. 1990 Apr;150(4):894-5.

119. Findling JW, Engeland WC, Raff H. The use of immunoradiometric assay for the measurement of ACTH in human plasma. Trends Endocrinol Metab. 1990;1(6):283-7.

120. Raff H, Findling JW. Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med. 1990 Sep;18(9):915-20.

121. Findling JW. Eutopic or ectopic adrenocorticotropic hormone-dependent Cushing's syndrome? A diagnostic dilemma. Mayo Clin Proc. 1990 Oct;65(10):1377-80.

122. Shaker JL, Krawczyk KW, Findling JW. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1990 Nov;71(5):1305-9.

123. Lewin RF, Raff H, Findling JW, Dorros G. Stimulation of atrial natriuretic peptide and vasopressin during retrograde mitral valvuloplasty. Am Heart J. 1990 Dec;120(6 Pt 1):1305-10.

124. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, Ling A, Travis WD, Cutler GB Jr, Chrousos GP. Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR Am J Roentgenol. 1991 Jan;156(1):39-43.

125. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int. 1991 Jun;1(3):177-81.

126. Findling JW, Kehoe ME, Shaker JL, Raff H. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab. 1991 Aug;73(2):408-13.

127. Findling JW. Clinical application of a new immunoradiometric assay for ACTH Endocrinologist. November 1992;2(6):360-365.

128. Dankle SK, Kidder TM, Findling JW. Tracheoesophageal complications of thyroid disease. Laryngoscope. 1992 Jul;102(7):739-46.

129. Findling JW, Mazzaferri EL. Cushing syndrome--an etiologic workup. Hosp Pract (Off Ed). 1992 Oct 15;27(10):107-12, 114-8, 121-2.

130. Shaker JL, Auger GE, Wendt PP, Findling JW. Hypercalcemia associated with dysregulation of 1,25-dihydroxyvitamin D in arthritis. J Endocrinol Invest. 1992 Nov;15(10):771-5.

131. Kay J, Raff H, Findling JW. Epidural triamcinolone causes prolonged and severe suppression of the pituitary-adrenal axis Regional Anesthesia. March-April 1993;18(2):55.

132. Slyper AH, Findling JW. Use of a two-site immunoradiometric assay to resolve a factitious elevation of ACTH in primary pigmented nodular adrenocortical disease. J Pediatr Endocrinol. 1994;7(1):61-3.

133. Raff H, Shaker JL, Nelson DK, Findling JW. Rapid measurement of corticotropin (ACTH) with a modified immunochemiluminescent assay. Clin Chem. 1994 Jul;40(7 Pt 1):1344.

134. Shaker JL, Redlin KC, Warren GV, Findling JW. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis. Am J Med Sci. 1994 Aug;308(2):115-8.

135. Kay J, Findling JW, Raff H. Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth Analg. 1994 Sep;79(3):501-5.

136. Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein BM, Raff H. Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab. 1994 Oct;79(4):1091-6.

137. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994 Nov 04;79(3):407-14.

138. Raff H, Shaker JL, Seifert PE, Werner PH, Hazelrigg SR, Findling JW. Intraoperative measurement of adrenocorticotropin (ACTH) during removal of ACTH-secreting bronchial carcinoid tumors. J Clin Endocrinol Metab. 1995 Mar;80(3):1036-9.

139. Shaker JL, Brickner RC, Divgi AB, Raff H, Findling JW. Case report: renal phosphate wasting, syndrome of inappropriate antidiuretic hormone, and ectopic corticotropin production in small cell carcinoma. Am J Med Sci. 1995 Jul;310(1):38-41.

140. Corvol P. Liddle's syndrome: heritable human hypertension caused by mutations in the Beta subunit of the epithelial sodium channel. J Endocrinol Invest. 1995;18(7):592-4.

141. O'Shaughnessy IM, Raff H, Findling JW. Factitious Cushing's syndrome: discovery with use of a sensitive immunoradiometric assay for corticotropin. Endocr Pract. 1995;1(5):327-9.

142. Findling JW, Shaker JL, Brickner RC, Riordan PR, Aron DC. Curbside consultation in endocrine practice: A prospective observational study Endocrinologist. July 1996;6(4):328-331.

143. Findling JW, Cerletty JM, Rapp RJ, McGreevy RB. Results of a community thyroid screening program: who will benefit? Endocr Pract. 1996;2(4):237-42.

144. Findling JW. Differential diagnosis of Cushing's syndrome Endocrinologist. January 1997;7(1 SUPPL.).

145. Repaske DR, Medlej R, Gültekin EK, Krishnamani MR, Halaby G, Findling JW, Phillips JA 3rd. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab. 1997 Jan;82(1):51-6.

146. Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab. 1997 Apr;82(4):1071-4.

147. Shaker JL, Brickner RC, Findling JW, Kelly TM, Rapp R, Rizk G, Haddad JG, Schalch DS, Shenker Y. Hypocalcemia and skeletal disease as presenting features of celiac disease. Arch Intern Med. 1997 May 12;157(9):1013-6.

148. Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1997 Jun;82(6):1780-5.

149. Lalande BM, Findling JW. Amelioration of licorice-induced hypokalemic rhabdomyolysis with dexamethasone: Case report and review of the literature Endocrinologist. September/October 1998;8(5):359-363.

150. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC. Pseudohypercortisoluria: Spurious elevation of urinary cortisol due to carbamazepine Endocrinologist. March/April 1998;8(2):51-54.

151. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab. 1998 Aug;83(8):2681-6.

152. Semple PL, Vance ML, Findling J, Laws ER Jr. Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery. 2000 Mar;46(3):553-8; discussion 558-9.

153. Findling JW. Inferior petrosal sinus sampling: pros and cons; when and where. J Endocrinol Invest. 2000 Mar;23(3):193-5.

154. Whitcomb JE, Findling JW, Raff H, Harnsher K. Randomized trial of oral hydrocortisone and its effect on emergency physicians during night duty. WMJ. 2000 Oct;99(7):37-41, 46.

155. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001 Mar;86(3):1066-71.

156. Shaker JL, Magill SB, Lalande BM, Brickner RC, Findling JW. Endocrine manifestations of celiac disease Endocrinologist. 2002;12(2):110-116.

157. Raff H, Shaker JL, Magill SB, Kehoe ME, Findling JW. PTHrP during petrosal sinus sampling. Clin Endocrinol (Oxf). 2002 Mar;56(3):419.

158. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med. 2003 Jun 17;138(12):980-91.

159. Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH. Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab. 2003 Aug;88(8):3521-4.

160. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602.

161. Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab. 2004 Mar;89(3):1222-6.

162. Findling JW, Kehoe ME, Raff H. Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent. J Clin Endocrinol Metab. 2004 Dec;89(12):6005-9.

163. Findling JW, Raff H. Cushing's syndrome Endocrinology and Metabolism Clinics of North America. June 2005;34(2).

164. Findling JW, Raff H. Cushing's Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab. 2006 Oct;91(10):3746-53.

165. Kidambi S, Raff H, Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol. 2007 Dec;157(6):725-31.

166. Findling J, Nieman L, Vigersky R. The hormone foundation's: Patient guide to the diagnosis of Cushing's syndrome Journal of Clinical Endocrinology and Metabolism. May 2008;93(5).

167. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40. PMCID: PMC2386281

168. Carroll T, Raff H, Findling JW. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome. Nat Clin Pract Endocrinol Metab. 2008 Jun;4(6):344-50.

169. Raff H, Brock S, Findling JW. Cosyntropin-stimulated salivary cortisol in hospitalized patients with hypoproteinemia. Endocrine. 2008;34(1-3):68-74.

170. Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab. 2009 Jan;94(1):115-22.

171. Mepani JB, Findling JW. Reversible bone marrow edema of the hip due to severe hypothyroidism. J Clin Endocrinol Metab. 2009 Apr;94(4):1068.

172. Carroll TB, Findling JW. Cushing's syndrome of nonpituitary causes. Curr Opin Endocrinol Diabetes Obes. 2009 Aug;16(4):308-15.

173. Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract. 2009;15(4):335-42.

174. Carroll TB, Findling JW. The diagnosis of Cushing's syndrome. Rev Endocr Metab Disord. 2010 Jun;11(2):147-53.

175. Raff H, Findling JW. Biomarkers: Salivary cortisol or cortisone? Nat Rev Endocrinol. 2010 Dec;6(12):658-60.

176. Ciric I, Zhao JC, Du H, Findling JW, Molitch ME, Weiss RE, Refetoff S, Kerr WD, Meyer J. Transsphenoidal surgery for Cushing disease: experience with 136 patients. Neurosurgery. 2012 Jan;70(1):70-80; discussion 80-1. PMCID: PMC4051420

177. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM, Pasireotide B2305 Study Group. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012 Mar 08;366(10):914-24.

178. Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C, SEISMIC Study Investigators. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49.

179. Carroll T, Findling JW. The use of mifepristone in the treatment of Cushing's syndrome. Drugs Today (Barc). 2012 Aug;48(8):509-18.

180. Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BM, Pasireotide B2305 Study Group. High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf). 2014 Feb;80(2):261-9. PMCID: PMC4231220

181. Boscaro M, Bertherat J, Findling J, Fleseriu M, Atkinson AB, Petersenn S, Schopohl J, Snyder P, Hughes G, Trovato A, Hu K, Maldonado M, Biller BM. Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study. Pituitary. 2014 Aug;17(4):320-6. PMCID: PMC4085509

182. Carroll TB, Fisco AJ, Auchus RJ, Kennedy L, Findling JW. Paradoxical Results after Inadvertent Use of Cosyntropin [Adrenocorticotropin Hormone (1-24)] Rather than Acthrel (Ovine Corticotropin Releasing Hormone) during Inferior Petrosal Sinus Sampling. Endocr Pract. 2014 Jul;20(7):646-9.

183. Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW. Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency. Case Rep Endocrinol. 2013;2013:675298. PMCID: PMC3881387

184. Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM, Pasireotide B2305 Study Group. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clin Endocrinol (Oxf). 2014 Sep;81(3):408-17.

185. Fleseriu M, Findling JW, Koch CA, Schlaffer SM, Buchfelder M, Gross C. Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone. J Clin Endocrinol Metab. 2014 Oct;99(10):3718-27. PMCID: PMC4399272

186. Findling JW. Evolution, global warming, smart phones, and late-night salivary cortisol. Endocr Pract. 2015 Feb;21(2):205-7.

187. Raff H, Auchus RJ, Findling JW, Nieman LK. Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how? J Clin Endocrinol Metab. 2015 Feb;100(2):395-7. PMCID: PMC4318888

188. Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW. Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients. Obes Surg. 2015 Dec;25(12):2306-13.

189. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A, Endocrine Society. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. PMCID: PMC4525003

190. Findling JW, Raff H. Neoplastic/pathological and nonneoplastic/physiological hypercortisolism: Cushing versus pseudo-cushing syndromes The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease: Cushing's Syndrome and Beyond. 1 January 2016:111-136.

191. Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS. Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol. Surgery. 2016 Jan;159(1):259-65.

192. Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS. Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol. Surgery. 2016 Jul;160(1):249-250.

193. Carroll TB, Javorsky BR, Findling JW. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL. Endocr Pract. 2016 Oct;22(10):1216-1223.

194. Findling JW, Fleseriu M, Newell-Price J, Petersenn S, Pivonello R, Kandra A, Pedroncelli AM, Biller BM. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study. Endocrine. 2016 Nov;54(2):516-523. PMCID: PMC5083774

195. Poonuru S, Findling JW, Shaker JL. Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome. Osteoporos Int. 2016 Dec;27(12):3645-3649.

196. Findling JW, Raff H. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome). Eur J Endocrinol. 2017 May;176(5):R205-R216.

197. Findling JW, Nieman L, Tabarin A. Diagnosis and Differential Diagnosis of Cushing's Syndrome. N Engl J Med. 2017 Jul 13;377(2):e3.

198. Wang TS, Kline G, Yen TW, Yin Z, Liu Y, Rilling W, So B, Findling JW, Evans DB, Pasieka JL. A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved. World J Surg. 2018 Feb;42(2):466-472.

199. Molitch ME, Findling JW, Clemmons DR. Excellence in the treatment of patients with pituitary tumors. Pituitary. 2018 Feb;21(1):107.

200. Findling JW, Raff H. Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor. Eur J Endocrinol. 2018 Mar;178(3):L3.

201. Guarda FJ, Findling J, Yuen KCJ, Fleseriu M, Nachtigall LB. Mifepristone increases thyroid hormone requirements in patients with central hypothyroidism: A multicenter study Journal of the Endocrine Society. 2019;3(9):1707-1714.

202. Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, Zarnecki K, Findling JW. Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol. J Endocr Soc. 2019 Jan 01;3(1):1-12. PMCID: PMC6291660

203. Greene LW, Geer EB, Page-Wilson G, Findling JW, Raff H. Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure-A Case Series. J Endocr Soc. 2019 Apr 01;3(4):763-772. PMCID: PMC6446888

204. Raff H, Cohen EP, Findling JW. A commentary on Diagnosing Cushing's disease in the context of renal failure. Eur J Endocrinol. 2019 Oct;181(4):C9-C11.

205. Wissner Greene L, Geer EB, Page-Wilson G, Findling JW, Raff H. Response to Letter to the Editor: "Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure-A Case Series". J Endocr Soc. 2020 Feb 01;4(2):bvz012. PMCID: PMC7033035

206. Yuen KCJ, Blevins LS Jr, Findling JW. Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic. Endocr Pract. 2020 Aug;26(8):915-922. PMCID: PMC7833469

207. Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ, Kim JH, Lacroix A, Laplanche A, O'Connell P, Tauchmanova L, Pedroncelli AM, Biller BMK, LINC 3 investigators. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol. 2020 Sep;8(9):748-761.

208. Kannankeril J, Carroll T, Findling JW, Javorsky B, Gunsolus IL, Phillips J, Raff H. Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome. J Endocr Soc. 2020 Oct 01;4(10):bvaa107. PMCID: PMC7480956

209. Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, Ceccato F, Daniele A, Detomas M, Di Dalmazi G, Elenkova A, Findling J, Grossman AB, Gomez-Sanchez CE, Heaney AP, Honegger J, Karavitaki N, Lacroix A, Laws ER, Losa M, Murakami M, Newell-Price J, Pecori Giraldi F, Pérez-Rivas LG, Pivonello R, Rainey WE, Sbiera S, Schopohl J, Stratakis CA, Theodoropoulou M, van Rossum EFC, Valassi E, Zacharieva S, Rubinstein G, Ritzel K. Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations. Eur J Endocrinol. 2021 Mar;184(3):P1-P16. PMCID: PMC8060870

210. Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, Findling JW. New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. 2021 Apr 01;5(4):bvab022. PMCID: PMC7975762

211. Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW. Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic Endocrinology, Diabetes and Metabolism. July 2021;4(3).

212. Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW. Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab. 2021 Jul;4(3):e00246. PMCID: PMC8250331

213. Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Jit Singh R, Colón-Franco JM, Findling JW. Response to the Letter to the Editor From Jialal and Sood: "New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency After ACTH Stimulation Using Specific Cortisol Assays". J Endocr Soc. 2021 Sep 01;5(9):bvab113. PMCID: PMC8279072

214. Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. PMCID: PMC8743006

215. Dream S, Park S, Yen TW, Rilling W, Rein L, Doffek K, Findling JW, Magill SB, Kidambi S, Evans DB, Wang TS. Utility of Epinephrine Levels in Determining Adrenal Vein Cannulation During Adrenal Venous Sampling for Primary Aldosteronism. Endocr Pract. 2022 Mar;28(3):276-281.

216. DeLozier OM, Dream SY, Findling JW, Carroll TB, Evans DB, Wang TS. Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism. J Clin Endocrinol Metab. 2022 Jan 18;107(2):e538-e547.

217. Orr M, Findling J, Zwagerman N, Connelly J, Albano K, Bovi J. Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature Advances in Radiation Oncology. 1 March 2022;7(2).

218. DeLozier OM, Dream S, Findling JW, Rilling W, Kidambi S, Magill SB, Evans DB, Wang TS. Wide Variability in Catecholamine Levels From Adrenal Venous Sampling in Primary Aldosteronism. J Surg Res. 2022 Sep;277:1-6.

219. Surani A, Carroll TB, Javorsky BR, Raff H, Findling JW. Alcohol-induced Cushing syndrome: report of eight cases and review of the literature. Front Endocrinol (Lausanne). 2023;14:1199091. PMCID: PMC10319132

220. Findling JW, Raff H. Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome. J Endocr Soc. 2023 Jul 03;7(8):bvad087. PMCID: PMC10334485

221. Armstrong SA, Tavakoli S, Shah I, Laing BR, Coss D, Ioachimescu AG, Findling J, Zwagerman NT. Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case. J Neurosurg Case Lessons. 2023 Nov 27;6(22). PMCID: PMC10684060

222. DeFronzo RA, Auchus RJ, Bancos I, Blonde L, Busch RS, Buse JB, Findling JW, Fonseca VA, Frias JP, Hamidi O, Handelsman Y, Pratley RE, Rosenstock J, Tudor IC, Moraitis AG, Einhorn D. Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone. BMJ Open. 2024 Jul 16;14(7):e081121. PMCID: PMC11253743

223. Johnson S, Zhang CD, Hangge PT, Yen TWF, Shaik TJ, Doffek K, Findling JW, Carroll T, Evans DB, Dream SY, Wang TS. Cosyntropin Stimulation Testing is More Selective than Postoperative Day 1 Basal Cortisol for Diagnosing Secondary Adrenal Insufficiency After Unilateral Adrenalectomy. Ann Surg Oncol. 2024 Oct;31(10):6883-6892.

224. Johnson S, Zhang CD, Hangge PT, Yen TWF, Shaik T, Doffek K, Findling JW, Carroll T, Evans DB, Dream SY, Wang TS. ASO Visual Abstract: Cosyntropin Stimulation Testing is More Selective Than Postoperative Day 1 Basal Cortisol for Diagnosing Secondary Adrenal Insufficiency Following Unilateral Adrenalectomy. Ann Surg Oncol. 2024 Aug 06.

1. Findling JW, Aron DC, Tyrrell JB: The anterior pituitary. In Basic and Clinical Endocrinology (Forsham PH and Greenspan FS, eds) Norwalk: Appleton & Lange (1st edition), 1983, (2nd edition), 1986, and (3rd edition), 1990, (4th edition), 1993, (5th edition), 1997, (6th edition), 2000, (7th edition), 2004, (8th edition)

2. Findling JW, Aron DC, Tyrrell JB: Cushing's disease. In The Pituitary (Imura H, ed), Raven Press, New York, 1985.

3. Aron DC, Findling JW, Tyrrell JB: Cushing's disease. In Endocrinology and Metabolism Clinics of North America. (Molitch M, ed) W. B. Saunders, Philadelphia 1987, pp. 705 730.

4. Findling JW, Raff H: Ectopic ACTH. In Endocrine Tumors (Mazzaferri EL, Samaan NA, eds). Cambridge 1993, pp.554 566.

5. Findling JW, Doppman JL: Biochemical and radiological diagnosis of Cushing's syndrome. Endocrinology and Metabolism Clinics of North America (Aron DC, Tyrrell JB, eds) W.B. Saunders Co., Philadelphia, 1994 pp.511 537.

6. Findling JW: The adrenal gland. In Medical Knowledge Self Assessment Program in Endocrinology and Metabolism, American College of Physicians, Philadelphia, 1995,pp.58 90.

7. Findling JW: Cushing's syndrome. In Current Diagnosis (Conn RB, Borer WZ, Snyder JW, eds). W.B. Saunders, Philadelphia, 1997, pp 778-783.

8. Findling JW, Aron DC, Tyrrell JB: Glucocorticoid and Adrenal Androgens In Basic and Clinical Endocrinology (Greenspan FS, Strewler GJ, eds) Norwalk: Appleton & Lange (5th edition), 1997, (6th edition), 2000, (7th edition), 2004.

9. Findling JW, Raff H: Newer Diagnostic Techniques and Problems in Cushing's Disease. In Endocrinology and Metabolism Clinics of North America. (Molitch M, ed) W. B. Saunders, Philadelphia, 1999, pp. 191-210.

10. Findling JW, Raff H: Diagnosis and Differential Diagnosis of Cushings Syndrome. Endocrinology and Metabolism Clinics of North America (Klibanski A, ed) W.B. Saunders, Philadelphia, 2001, pp 729-747.

11. Findling JW: Cushing's syndrome. Contemporary Endocrinology: Challenging Cases in Endocrinology (Molitch ME, ed). Humana Press, Inc., Totowa, NY 2002, pp.119-136.

12. Findling JW, Raff H; Guest Editors, Cushing's Syndrome Endocrinology and Metabolism Clinics of North America W.B. Saunders, Philadelphia, 2005.

13. Findling JW, Raff H: Screening and diagnosis of Cushing's Syndrome. Endocrinology and Metabolism Clinics of North America (Findling JW, Raff H, eds) W.B. Saunders, Philadelphia, 2005, pp. 385-402.

14. Findling JW, Raff H: Cushing's disease: diagnostic evaluation. Diagnosis and Management of Pituitary Disorders (Swearingen B, Biller BMK, eds). Humana Press, 2008, pp 187-202.

15. Kaur K, Findling JW: Cushing's Disease. In A Case-Based Guide to Clinical Endocrinology, pp 27-36, 2008. Humana Press, Inc., Ed. Davies TF.

16. Javorsky BR, Findling JW: Inferior petrosal sampling for the differential diagnosis of ACTH-dependent Cushing's syndrome. Cushing's Syndrome: Pathophysiology, Diagnosis and Treatment. Ed: Marcello D Bronstein. 1st ed. The Humana Press, Inc. 2010.

17. Findling JW, Doppman JL. Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 1994 Sep;23(3):511-37.

18. Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am. 1999 Mar;28(1):191-210.

19. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 2001 Sep;30(3):729-47.

20. Findling JW, Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 2005 Jun;34(2):385-402, ix-x.

21. He X, Findling JW, Auchus RJ. Diagnosis and management of adrenal insufficiency Contemporary Endocrinology. 2018:199-215.

1. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, and Forsham PH: Selective venous sampling for ACTH in Cushing's syndrome. Horm Res 13:334 335, 1980 (oral presentation).

2. Aron DC, Findling JW, Tyrrell JB, Fitzgerald PA, and Forsham PH: The overnight high dose dexamethasone suppression test: a rapid method of differential diagnosis in Cushing's syndrome. Horm Res 13:334, 1980 (oral presentation).

3. Findling JW, Tyrrell JB, Adams ND, Gray RW, Lemann J Jr, and Forsham PH: Vitamin D metabolism and parathyroid function before and after treatment of Cushing's syndrome. Program of the 63rd Annual Meeting of The Endocrine Society, Cincinnati, Ohio, June 17 19, 2981, p. 27. (oral presentation).

4. Findling JW, Tyrrell JB, Adams ND, Gray RW, Lemann J Jr, and Forsham PH: Calcium and phosphorus homeostasis in Cushing's syndrome: relationship to vitamin D metabolites and parathyroid hormone. Program of the International Symposium on Corticoids and the Metabolism of Calcium and Phosphorus: Eleventh Congress of the European Society of Osteoarthrology, Prague, September 7 9, 1981 (unpaginated) (oral presentation).

5. Findling JW, Hane S, Tyrrell JB, and Baxter JD: Total and free plasma cortisol response to ACTH: a comparison of five methods. Program of the 64th Annual Meeting of the The Endocrine Society, San Francisco, June 16 18, 1982, p. 343 (poster presentation).

6. Segerson TP, Raff H, Katzoff MN, Levy SA, Findling JW. Intermittent ectopic Cushing's syndrome: Localization of an occult ACTH source by selective bronchial lavage for ACTH. 7th International Congress of Endocrinology, Excerpta Medica, Amsterdam 1984, p. 1395 (poster presentation).

7. Segerson TP, Findling JW, Raff H: Effect of indomethacin on potassium stimulated aldosterone secretion. Federation Proceedings 44:4613, 1985 (poster presentation).

8. Waters VO, Findling JW, Raff H: Correlation of angiotensin II and renin levels in critically ill patients. Federation Proceedings 44:6786, 1985 (poster presentation).

9. Waters VO, Raff H, Findling JW: Measurement of renin, angiotensin II, and aldosterone levels in critically ill patients. Critical Care Med 13:282, 1985 (poster presentation).

10. Findling JW, Waters VO, Segerson TP, Raff H: Hyperreninemic hypoaldosteronism in the critically ill: evaluation of angiotensin II, ACTH, and potassium levels. Program of the 67th Annual Meeting of the The Endocrine Society, Baltimore, 1985 Abst 546 pg 137 (poster presentation).

11. Findling JW, Segerson T, Gotch P, Raff H, Schmahl T, Tector A: Use of a continuous intravenous insulin infusion in 101 diabetic cardiac surgery patients. Diabetes 35 (1): 117A, 1986 (poster presentation).

12. Findling JW, Adams AH, Raff H: Endogenous angiotensin II deficiency: a cause of selective hypoaldosteronism. Clin Res 34:908A, 1986 (poster presentation).

13. Raff H, Flemma RJ, Norton AJ, Findling JW: Angiotensin II generation during cardiopulmonary bypass in humans. Federation Proceedings 46:1266, 1987 (poster presentation).

14. Raff H, Nelson DK, Norton AJ, Flemma RJ, Findling JW: Inhibition of the ACTH response to surgery in humans: corticosteroid fentanyl interaction. Endocrinology 120:142A, 1987 (poster presentation).

15. Findling J, Kehoe M, Raff H: Bilateral petrosal sinus ACTH sampling in Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. Clin Res 35:844A, 1987 (oral presentation).

16. Raff H, Lewin RF, Skelton MM, Cowley AW, Findling JW, King JF, Dorros G: Transient aortic obstruction increases atrial natriuretic peptide and vasopressin but not renin levels in patients with heart failure. FASEB Journal 2:A307, 1988 (poster presentation).

17. Findling JW, Shaker JL, Kehoe ME: The occult ectopic ACTH syndrome: early recognition with the use of ovine corticotropin releasing hormone stimulation during bilateral petrosal sinus sampling. Endocrinology 122:51A, 1988.

18. Diaz SD, Waters VO, Raff H, Findling JW: Dissociation of renin and aldosterone in critical illness: responses to ACTH and metoclopramide. Endocrinology 122:250A, 1988 (poster presentation).

19. Shaker J, Norton A, Woods M, Findling J: Osteopenia and secondary hyperparathyroidism following gastric exclusion for obesity. J Bone Min Res 3 (1): 166, 1988 (poster presentation).

20. Raff H, Lewin RF, Skelton MM, Cowley AW, Findling JW, King JF, Dorros G: Atrial septal puncture and initial valve obstruction independently increase atrial natriuretic peptide in patients with congestive heart failure. FASEB Journal 3:A917, 1989 (poster presentation).

21. Findling JW, Kehoe ME, Raff H: Differentiation of the occult ectopic ACTH syndrome from Cushing's disease with the use of ovine corticotropin releasing hormone stimulation during bilateral petrosal sinus ACTH sampling. International Symposium on Challenges of Hypersecretion: ACTH, Cushing's syndrome and other hypercortisolemic states. Greece, Crete, Aghia Pelaghia, p. 10. April 14, 1989 (poster presentation).

22. Findling JW, Shaker JL, Hanson JP, Engeland W, Graeber CT, Wong J, Raff H: Clinical evaluation of a two site immunoradiometric assay for ACTH (1 39) in normal subjects and patients with pituitary adrenal disorders. Program of 71st Annual Meeting of the Endocrine Society, p. 100, 1989 (poster presentation).

23. Raff H, Findling JW, Wong J: Ultrasound short loop inhibition of ACTH secretion after ACTH (1 24) administration in man cannot be detected by two site immunoradiometric assay. Program of 71st Annual Meeting of the Endocrine Society, p. 100, 1989 (poster presentation).

24. Raff H, Brummitt C, Buggy B, Gilson I, McNamara M, Findling J: Subnormal aldosterone responses to ACTH in patients with HIV infection. Clin Res 37:897A, 1989 (poster presentation).

25. Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein B: Subnormal aldosterone responses to ACTH in patients with the acquired immunodeficiency syndrome (AIDS). Program of 72nd Annual Meeting of the Endocrine Society p. 231, 1990 (poster presentation).

26. O'Shaughnessy I, Findling JW: Factitious Cushing's syndrome: discovery with the use of a immunoradiometric assay (IRMA) for ACTH during petrosal sinus sampling. Program of 73rd Annual Meeting of the Endocrine Society, p. 46, 1991 (poster presentation).

27. Raff H, Nelson DK, Findling JW, Kay J: Acute and chronic suppression of ACTH and cortisol after epidural steroid administration in humans. Program of 73rd Annual Meeting of the Endocrine Society, p. 47, 1991 (poster presentation).

28. Shaker JL and Findling JW. High calcium concentration within a parathyroid cyst: possible local effect of PTH. Journal of Bone and Mineral Research, Program and Abstracts, p. s302, August 1991 (poster presentation).

29. Shaker JL, Auger GE, Wendt PP, and Findling JW. Hypercalcemia associated with dysregulation of calcitriol in degenerative arthritis. Journal of Bone and Mineral Research, Program and Abstracts, p. s306, August 1991 (poster presentation).

30. Wahle JS, Hanson JP, Shaker JL, Findling JW: Autoimmune Addison's disease after treatment with interleukin 2 and tumor infiltrating lymphocytes. Program of 74th Annual Meeting of the Endocrine Society p.266,1992 (poster presentation).

31. Shaker JL, Redlin KC, Warren GV, Findling JW: Hypercalcemia with inappropriate 1,25 dihydroxyvitamin D in Wegener's granulomatosis. Program of the 74th Annual Meeting of the Endocrine Society p.213,1992 (poster presentation).

32. Findling JW: Inferior petrosal sinus sampling in the differential diagnosis of ACTH dependent Cushing's syndrome: requiem for dexamethasone suppression testing. Program of the 74th Annual Meeting of the Endocrine Society p.46,1992 (oral presentation).

33. Findling JW, Buggy BP, Brummitt CF, Gilson IH, Bernstein BM: Longitudinal evaluation of adrenocortical function in patients with HIV infection. Program of the 75th Annual Meeting of the Endocrine Society , p.465, 1993 (poster presentation).

34. Raff H, Shaker JL, Seifert PE, Werner PH, Hazelrigg SR, Findling JW: Intraoperative measurement of ACTH during removal of ACTH secreting bronchial carcinoid tumors. Program of the 76th Annual Meeting of the Endocrine Society, p.211, 1994 (poster presentation).

35. Brickner RC, Raff H, Shaker JL, Findling JW: Increased ACTH by immunoradiometric assay is an early indicator of primary adrenal insufficiency. Program of the 76th Annual Meeting of the Endocrine Society, p.517, 1994 (poster presentation).

36. Shaker JL, Findling JW, Brickner RC, Riordan PR, Aron DC: Curbside consultation in endocrine practice: a prospective study. Program of the 77th Annual Meeting of the Endocrine Society, p.130,1995 (poster presentation).

37. Findling JW, Raff H, Hansson JH, Litton RP: Liddle's syndrome: a new kindred with a unique mutation in the b subunit of the renal epithelial sodium channel clinically identified by hypoaldosteronism. Program of the 77th Annual Meeting of the Endocrine Society, p.59,1995 (oral presentation).

38. Raff H, Kehoe ME, Findling JW: DDAVP increases inferior petrosal sinus ACTH concentration in patients with pituitary and ectopic ACTH dependent Cushing's syndrome. Program of the 77th Annual Meeting of the Endocrine Society, p.100,1995 (poster presentation).

39. Shaker JL, Kay J, Findlng JW, Raff H: Epidural corticosteroid therapy is associated with a decrease in plasma osteocalcin. 10th Internation Congress of Endocrinology. p377, 1996 (poster presentation).

40. Aron DC, Raff H, Findlng JW: The limited value of high dose dexamethasone suppression testing in diagnosis of Cushing's syndrome. 10th International Congress of.Endocrinology p51, 1996 (oral presentation).

41. Findling JW, Kehoe ME, Shaker JL, Brickner RC, Raff H: Correlation of the interpetrosal sinus gradient with the location of ACTH secreting microadenomas. Program of the 4th International Pituitary Congress, pF9, 1996 (poster presentation).

42. Raff H, Raff JL, Findling JW: Measurement of salivary cortisol in normal subjects and patients with Cushing syndrome. Program of the 79th Annual Meeting of the Endocrine Sociey, p105, 1997 (oral presentation).

43. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW: Comparison of adrenal vein sampling and CT in the differentiation of primary aldosteronism. Program of the 79th Annual Meeting of the Endocrine Sociey, p477, 1997 (oral presentation).

44. Raff JL, Raff H, Findling JW, Rudman I, Mattson D, Hammel G, Sasse E, Sheldahl L, Wilson C, Duthie E: Salivary cortisol levels are elevated in the evening in elderly woman and men. Program of the 80th Annual Meeting of the Endocrine Society, p , 1998 (poster presentation).

45. Findling JW, Shaker JL, Brickner RC, Magill SB, Lalande BM, Raff H: Low-dose dexamethasone suppression testing cannot be used to exclude Cushing's Syndrome. Program of the 81th Annual Meeting of the Endocrine Society, p90, 1999 (oral presentation).

46. Raff H, Findling JW, Singh RJ: Salivary cortisol/cortisone measurements: Cushing's syndrome and statins. Program of the 83rd Annual Meeting of the Endocrine Society, p95, 2001 (oral presentation).

47. Findling JW: Salivary cortisol: eulogy for dexamethasone suppression and urine cortisol. Program of the 85th Annual Meeting of the Endocrine Society, p48, 2003 (oral presentation).

48. Sujatanond P, Shaker JL, Lalande BM, Magill S, Raff H, Findling JW: Hyperthyroidism increases morbidity in patients who undergo open heart surgery: a retrospective analysis at a single institution. Program of the 85th Annual Meeting of the Endocrine Society, p254, 2003 (poster presentation).

49. Taylor RL, Grebe SK, Findling JW, Raff H, Singh RJ: Diagnosis of Cushing's syndrome with a sensitive and specific LC-MS/MS method for late night salivary cortisol. Program of the 85th Annual Meeting of the Endocrine Society, p444, 2003 (poster presentation).

50. Findling JW, Kehoe, ME, Raff H: Prolactin as an index of pituitary venous effluent: identification of patients with Cushing's disease with negative pituitary ACTH gradients during inferior petrosal sinus sampling. Program of the 86th Annual Meeting of the Endocrine Society, p.418, 2004 (poster presentation).

51. Liu H, Cabaecan J, Raff H, Findling J. Ryzen E: Late-night salivary cortisol as a screening test for Cushing's Syndrome in male obese diabetic veterans. Program of the 87th Annual Meeting of the Endocrine Society, p487, 2005 (poster presentation).

52. Brock S, Raff H, Findling JW; Cosyntropin-stimulated salivary cortisol as a surrogate for serum free cortisol in hospitalized patients. Program of the 87th Annual Meeting of the Endocrine Society, p649, 2005 (poster presentation).

53. Kidambi S, Raff H, Findling JW: The diagnosis of mild Cushing's syndrome in patients with normal urine free cortisol: utility of nocturna salivary cortisol. Program of the 88th Annual Meeting of the Endocrine Society, p864, 2006 (poster presentation).

54. Boscaro M, Petersenn S, Atkinson AB, Betherat J, Findling J; et al: Pasireotide (SOM 230), the novel multi-ligand somatostatin analogue, is a promising medical therapy for patients with Cushing's disease: a preliminary safely and efficacy results of a Phase II Study. Program of the 88th Annual Meeting of the Endocrine Society, p81, 2006 (oral presentation).

55. Findling J: Endogenous hypercortisolism: Not your mentor's Cushing syndrome. Program of the 89th Annual Meeting of the Endocrine Society, p.64, 2007 (oral presentation).

56. Carroll T, Raff H, Findling JW: Nocturnal salivary cortisol for the diagnosis of Cushing's syndrome: a meta-analysis. Program of the 90th Annual Meeting of the Endocrine Society, p.146, 2008 (oral presentation).

57. Findling JW: Optimal management of managing cyclical Cushing's disease. Program of the 91st Annual Meeting of The Endocrine Society. p. B-11, 2009 (oral presentation).

58. Mepani JB, Findling JW, Salvatori R, Toth DW, Nora EH, Raff H: Discordant late-night salivary cortisol results: a retrospective analysis. Program of the 91st Annual Meeting of The Endocrine Society. p. 40, 2009 (poster presentation).

59. Boscaro M, Zhang Y, Sen K, Maldonado M, Schoenherr U, Findling J. UFC response is related to pasireotide (SOM230) plasma concentrations in patients with Cushing's disease. Presented at the 14th International Congress of Endocrinology (ICE), Kyoto, Japan 2010; P7-6-4 (poster presentation).

60. Boscaro M, Zhang Y, Sen K, Maldonado M, Schoenherr U, Findling J. UFC response is related to pasireotide (SOM230) plasma concentrations in patients with Cushing's disease. Presented at the 14th International Congress of Endocrinology (ICE), Kyoto, Japan. 2010;Poster P7-6-4 (poster presentation).

61. Boscaro M, Zhang Y, Sen K, Maldonado M, Schoenherr U, Findling JW. Long-term treatment of Cushing's disease with pasireotide (SOM230): results from a Phase II extension study. Endocr Rev. 2010;31(3 Suppl 1):S333 (abst P1-274). (Presented as a poster at ENDO 2010)

62. Boscaro M, Zhang Y, Sen K, Maldonado M, Schoenherr U, Findling J. Long-term treatment of Cushing's disease with pasireotide (SOM230): results from a Phase II extension study. Endocrine Abstracts (2010) 22 P640. (Presented as a poster at ECE 2010)

63. Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado, Sen K, Salgado LR, Colao A and Biller BMK on behalf of the Pasireotide B2305 Study Group. Baseline characteristics and urine free cortisol (UFC) variability of 162 patients enrolled in a randomized, double-blind phase III study assessing the efficacy and safety of pasireotide (SOM230) in patients with Cushing's disease. Endocr Rev. 2010;31(3 Suppl 1): S332 (abst P1-273). (Presented as a poster at ENDO 2010)

64. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldano M, Schoenherr U, Mills D, Saldago LR, Biller BMK. Pasireotide (SOM230) provides clinical benefit in patients with Cushing's disease: results form a large, 12-month, randomized-dose, double-blind, Phase III study. Presented at the 14th Congress of the European NeuroEndocrine Association (ENEA), Liege, Belgium, 2010; OC-1.7 (Oral presentation)

65. Fisco AJH, Carroll TB, Auchus RJ, Findling JW. Paradoxical results after inadvertent use of ACTH(1-24) rather than ACTHrel (ovine corticotropin-releasing hormone) during inferior petrosal sinus sampling. Presented at 93rd Annual Meeting of the Endocrine Society. Boston, MA (2011) (poster)

66. Fleseriu M, Biller BMK, Findling JW, Molitch ME, Schteingart DE, Gross C. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with refractory Cushing's syndrome (SEISMIC). Presented at 93rd Annual Meeting of the Endocrine Society, Boston, MA (2011) (oral presentation).

67. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BMK. Pasireotide (SOM 230) demonstrates efficacy in patients with Cushing's disease: results from a large, randomized-dose, double-blind, Phase III Study. Presented at 93rd Annual Meeting of the Endocrine Society, Boston, MA (2011) (oral presentation).

68. Aron DC, Findling JW, Tyrrell JB. The overnight high-dose dexamethasone suppression test: A rapid method of differential diagnosis in Cushing's syndrome Hormone Research. 1980;13(4-5):334.

69. Waters VO, Findling JW, Raff H. Correlation of angiotensin II and renin levels in critically ill patients Federation Proceedings. 1985;44(5).

70. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med. 1986 Feb;104(2):180-6.

71. Wahle JS, Hanson JP, Shaker JL, Findling JW. Autoimmune Addison's disease after treatment with interleukin-2 and tumor-infiltrating lymphocytes. Endocr Pract. 1995;1(1):14-7.

72. He X, Findling JW, Auchus RJ. Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome. Pituitary. 2022 Jun;25(3):393-403. PMCID: PMC9170649